摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,6,10,13-四硫化环十四烷-1-氧基)己酸 | 162316-51-0

中文名称
2-(3,6,10,13-四硫化环十四烷-1-氧基)己酸
中文别名
——
英文名称
Ttctoha
英文别名
2-(1,4,8,11-tetrathiacyclotetradec-6-yloxy)hexanoic acid
2-(3,6,10,13-四硫化环十四烷-1-氧基)己酸化学式
CAS
162316-51-0
化学式
C16H30O3S4
mdl
——
分子量
398.7
InChiKey
ZIRYKADCKCUEGL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    602.8±55.0 °C(Predicted)
  • 密度:
    1.20±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    148
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • MEANS FOR THE QUANTITATIVE DETERMINATION OF AN ANALYTE CONCENTRATION IN A PATIENT'S URINE SAMPLE
    申请人:Fuhrmann, Gerda Laura
    公开号:EP3537153A1
    公开(公告)日:2019-09-11
    The present invention relates to a single-use monoanalytical test-strip for the quantitative determination of an analyte in a patient's urine sample, and to a non-invasive point-of-care (POC) device for detecting deficiency and/or overload of an analyte in a patient's body. Furthermore, the present invention relates to a method for quantitatively determining the concentration of an analyte in a patient's urine sample and to a method of detecting deficiency and/or overload of an analyte in a patient's body. The test-strip comprises a substrate which either is electrically insulating or which has an electrically insulating layer applied thereon,- an electrode assembly applied on said substrate or on said electrically insulating layer, if present; and said electrode assembly comprises at least- one analyte-selective working electrode;- one reference electrode for said analyte-selective working electrode and an interface for electrically connecting said electrode assembly to a read out-meter device. Analytes are anions selected from halides, phopshates and sulfates or cations of alkali metals, of alkaline earth metals or of other metals.
    本发明涉及一种用于定量测定患者尿样中分析物的一次性单分析试纸,以及一种用于检测患者体内分析物缺乏和/或过量的非侵入性护理点(POC)设备。此外,本发明还涉及一种定量测定患者尿样中分析物浓度的方法,以及一种检测患者体内分析物缺乏和/或过量的方法。检测条包括一个基板,该基板是电绝缘的,或者在其上涂有电绝缘层;- 一个电极组件,如果有的话,涂在所述基板上或所述电绝缘层上;所述电极组件包括至少--一个分析物选择性工作电极;--一个用于所述分析物选择性工作电极的参比电极,以及一个用于将所述电极组件电连接到读出计装置的接口。分析物为阴离子,选自卤化物、磷酸盐和硫酸盐或碱金属、碱土金属或其他金属的阳离子。
  • MEANS FOR THE QUANTITATIVE DETERMINATION OF CATIONIC ELECTROLYTE CONCENTRATION AND CREATININE CONCENTRATION AND OF THEIR RATIOS
    申请人:UriSalt GmbH
    公开号:EP3640633A1
    公开(公告)日:2020-04-22
    The present invention relates to a single-use test strip for the quantitative determination of a concentration of a cationic electrolyte which is not sodium, and of creatinine concentration, and for the subsequent determination of their ratio, and to a non-invasive point-of-care (POC) device for detecting a disorder of electrolyte balance in patient's body. Furthermore, the present invention relates to a method for simultaneously and quantitatively determining a cationic electrolyte concentration and creatinine concentration in a patient's urine sample and to a method of detecting a disorder of electrolyte balance in a patient's body.
    本发明涉及一种一次性试纸,用于定量测定非钠的阳离子电解质浓度和肌酐浓度,以及随后测定它们的比值,还涉及一种用于检测患者体内电解质平衡失调的非侵入性护理点(POC)设备。此外,本发明还涉及一种同时定量测定患者尿样中阳离子电解质浓度和肌酐浓度的方法,以及一种检测患者体内电解质平衡失调的方法。
  • LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE AND IONOPHORE CONTAINING LIPOSOMES IN WHICH THE IONOPHORE IS 2-HYDROXYQUIONOLINE (CARBOSTYRIL) OR STRUCTURALLY RELATED 2-HYDROXYQUINOLINES
    申请人:Technical University of Denmark
    公开号:EP2453927A1
    公开(公告)日:2012-05-23
  • ENTRAPMENT OF RADIONUCLIDES IN NANOPARTICLE COMPOSITIONS
    申请人:Technical University of Denmark
    公开号:EP2651447A1
    公开(公告)日:2013-10-23
  • LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE CONTAINING NANOPARTICLES
    申请人:Petersen Anncatrine Luisa
    公开号:US20120213698A1
    公开(公告)日:2012-08-23
    The present invention relates to a novel composition and method for loading delivery systems such as liposome compositions with radionuclides useful in targeted diagnostic and/or therapy of target site, such as cancerous tissue and, in general, pathological conditions associated with leaky blood vessels. The composition and methods of the invention find particular use in diagnosing and imaging cancerous tissue and, in general, pathological conditions associated with leaky blood vessels in a subject. The present invention provides a new diagnostic tool for the utilization of positron emission tomography (PET) imaging technique. One specific aspect of the invention is directed to a method of producing nanoparticles with desired targeting properties for diagnostic and/or radio-therapeutic applications.
查看更多